Comprehensive comparison of the prognostic value of systemic inflammation biomarkers for cancer cachexia: a multicenter prospective study
Hailun Xie(Guangxi Medical University), Hanping Shi(Beijing Shijitan Hospital), Guo‐Tian Ruan(Beijing Friendship Hospital), Shiqi Lin(Nanjing University of Information Science and Technology), Chunhua Song(Zhengzhou University), Mengmeng Song(China Pharmaceutical University), Heyang Zhang(Academy of Military Medical Sciences), Qi Zhang(East China University of Science and Technology), Xi Zhang(Capital Medical University), Xiaoyue Liu(Zhejiang University), Li Deng(Capital Medical University), Yi‐Zhong Ge(China International Science and Technology Cooperation), Ming Yang(Jiangsu University), Lishuang Wei(Guangxi Medical University), Meng Tang(Capital Medical University)
Cited by 21
Related Papers
Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study
|Frontiers in Immunology|2023|189
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer
|Journal of Cachexia Sarcopenia and Muscle|2022|170
A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment
|Journal of Neuroinflammation|2020|167
A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer
|Frontiers in Endocrinology|2022|161
Inflammatory burden as a prognostic biomarker for cancer
|Clinical Nutrition|2022|152